ANR — Anatara Lifesciences Balance Sheet
0.000.00%
- AU$3.41m
- AU$3.72m
Annual balance sheet for Anatara Lifesciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3.43 | 1.17 | 0.401 | 0.982 | 0.101 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.773 | 0.509 | 1 | 0.671 | 1.03 |
| Total Other Current Assets | |||||
| Total Current Assets | 4.24 | 1.7 | 1.42 | 1.67 | 1.15 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.085 | 0.067 | 0.003 | 0.001 | 0 |
| Total Assets | 4.33 | 1.77 | 1.42 | 1.67 | 1.15 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.403 | 0.358 | 0.494 | 0.304 | 0.607 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.497 | 0.403 | 0.495 | 0.307 | 0.612 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3.83 | 1.36 | 0.925 | 1.36 | 0.536 |
| Total Liabilities & Shareholders' Equity | 4.33 | 1.77 | 1.42 | 1.67 | 1.15 |
| Total Common Shares Outstanding |